Italia markets closed

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
122,28+1,23 (+1,02%)
Alla chiusura: 04:00PM EDT
122,28 0,00 (0,00%)
Dopo ore: 04:18PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente121,05
Aperto119,65
Denaro122,13 x 600
Lettera122,36 x 100
Min-Max giorno118,97 - 123,73
Intervallo di 52 settimane89,00 - 213,91
Volume793.687
Media Volume1.648.930
Capitalizzazione19,474B
Beta (5 anni mensile)1,19
Rapporto PE (ttm)N/D
EPS (ttm)-7,34
Prossima data utili02 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A152,15
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera